Bio Alexis EN

Alexis Peyroles

Biotech CEO and entrepreneur with a strong finance background and an international experience of 25 years mainly in Biotech and Pharma.
Major achievements in developing growth strategies, fundraising, licensing agreements, leading multicultural teams, improving operations management.

Along his career Alexis has developed an expertise in Strategy, Finance, Growth and Scale-up of innovative companies while driving change in France and in Emerging Markets. Worked in Japan, Eastern Europe, Brazil and France for both small and medium size companies as well as international corporations.

He joined HMR in 1996 as Financial Controller in Japan before becoming Head of Financial Control for the Baltic States for Sanofi. He was subsequently named Head of activities for Business Development in Eastern Europe.

From 2002 to 2005 Alexis created the subsidiary in Lyon of Ideactif, a communication agency where he acted also as Group Finance manager.

In 2005, Alexis joined the Guerbet group (a leader in the field of contrast products, especially in medical imaging) as Financial Control Manager becoming a member of the Group Executive Committee in 2007. In 2009 he was nominated as General Manager for Latin America, based in Brazil until 2012.

In 2013 Alexis Peyroles joined OSE Immunotherapeutics, a French listed biotech company focused on Immunotherapy, in the first year after its founding. He served initially as Chief Operating Officer, in charge of Business Development, Finance and Operations and in April 2018 became CEO and Board member of OSE Immunotherapeutics until early 2022.

In July 2022, he co-founded Inside Therapeutics, a DeepTech company revolutionizing mRNA manufacturing and is Chairman of the Strategic Committee.

In August 2024 he co-founded OWL Lifesciences, a company specialised on the discovery test of therapeutic targets and carriers for Central Nervous System unmet conditions using organoids and is Chairman of the Strategic Committee.

Alexis Peyroles is graduated from EDHEC Business School and holds an Executive MBA from Imperial College in London.